ArticleCell communication and signaling : CCS2026
Loss of L1CAM from gastric epithelial cells and extracellular vesicles promotes Helicobacter pylori-driven cancer progression and invasiveness.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundHelicobacter pylori (Hp) infection is a major risk factor for gastric cancer (GC). While Hp-driven alterations in host signaling have been widely studied, the contribution of extracellular vesicles (EVs) to this process remains largely unexplored. Cell adhesion molecules play key roles in maintaining epithelial integrity and their dysregulation is often associated with malignant transformation. L1 cell adhesion molecule (L1CAM), a transmembrane protein involved in cell-cell interactions and signaling, has been implicated in cancer progression but its regulation in the context of Hp infection remains unclear. Here, we aimed to determine the relevance of L1CAM regulation and its EV-associated dynamics in Hp infection-induced GC.
methodsL1CAM status was assessed in Hp-positive gastric biopsy specimens by immunofluorescence microscopy and by western blotting of Hp-infected gastric epithelial cells (GECs). EVs from infected GECs were isolated and characterized. Functional assays, including proliferation, migration and xenograft studies were performed using infected or uninfected L1CAM-overexpressing as well as empty-vector cell-derived EVs. Integrin modulation by L1CAM was assessed by immunoblotting and microscopy in in vitro studies, patient samples and xenograft models using L1CAM-modulated cells. Epithelial-mesenchymal transition (EMT) markers, L1CAM proteolysis and inhibition studies were analyzed by immunoblotting to delineate the underlying molecular mechanisms.
resultsHp infection caused a marked loss of the full-length (FL) L1CAM in GECs and secreted GEC-EVs. A similar decrease was observed in Hp-positive GC tissues and plasma-derived EVs. Mechanistically, Hp-driven loss of FL-L1CAM resulted from the metalloproteinase ADAM10-mediated cleavage and was accompanied by the appearance of L1CAM fragments in infected cells or their EVs. EVs derived from infected cells significantly enhanced proliferation and migration of non-cancerous GECs in vitro as well as promoted tumor growth in vivo. In contrast, EVs from uninfected cells attenuated these malignant traits, suggesting that Hp-associated proteolytic depletion of FL-L1CAM fosters a tumor-promoting phenotype. Additionally, loss of FL-L1CAM induced EMT and selectively decreased αVβ1 integrin across infected cells, patient biopsies and xenograft tissues, defining a distinct Hp-driven L1CAM-ADAM10-αVβ1 signaling axis.
conclusionHp-induced proteolytic cleavage of L1CAM represents a distinct molecular signature of Hp-associated GC. FL-L1CAM-depleted EV may serve as a promising minimally invasive biomarker in Hp-driven gastric carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.